Skip to content

Articaine Efficiency in Pulpectomy of Children With Irreversible Pulpitis Under the Age of Four

Articaine Success in Pulpectomy of Primary Molars With Irreversible Pulpitis in Children Under Four Years: a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05944341
Enrollment
164
Registered
2023-07-13
Start date
2023-06-01
Completion date
2023-07-15
Last updated
2023-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Pulp Diseases

Brief summary

A two-tailed randomized controlled trial with two parallel arms is aimed to compare success proportions of the articaine and lidocaine groups in children with irreversible pulpitis under 4 years. The participants will be randomly assigned into two equal groups (82 children per group): the control group will receive lidocaine and the intervention group will receive the articaine local anesthesia. The direct observation tool FLACC was considered to assess pain severity. The behavior was assessed during pulpectomy procedures using the Frankl behavior rating scale (FBRS)

Interventions

DRUGarticaine hydrochloride 4% with epinephrine 1:100 000

Local anesthetic agent

Sponsors

Minia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
36 Months to 47 Months
Healthy volunteers
Yes

Inclusion criteria

* Healthy 36-47 month-children (ASA class I or II) weighing at least 15 kilograms * Children should be intellectually fit, and cooperative, with no behavior or communication abnormalities * Presence of a carious maxillary or mandibular second primary molars with signs and symptoms of irreversible pulpitis

Exclusion criteria

* Molars with unrestorable crowns * Molars with necrotic pulps, pathological mobility, gingival swelling or abscess, fistulous or sinus tract, or apical periodontitis

Design outcomes

Primary

MeasureTime frameDescription
Face, Legs, Activity, Cry, Consolability pain scaleup to 24 hoursits scores range from None/mild pain scores 0-3 Moderate pain scores 4-6 Severe pain scores 7-10

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026